StockNews.com Lowers InfuSystem (NYSEAMERICAN:INFU) to Buy

StockNews.com downgraded shares of InfuSystem (NYSEAMERICAN:INFU) from a strong-buy rating to a buy rating in a research report report published on Tuesday morning.

Separately, Lake Street Capital raised InfuSystem to a strong-buy rating in a report on Thursday, May 9th.

InfuSystem Stock Down 1.8 %

Shares of INFU stock opened at $6.15 on Tuesday. The company has a current ratio of 1.87, a quick ratio of 1.51 and a debt-to-equity ratio of 0.57. The stock has a market capitalization of $131.00 million, a price-to-earnings ratio of -615,000.00 and a beta of 1.44. InfuSystem has a fifty-two week low of $5.74 and a fifty-two week high of $10.99.

InfuSystem (NYSEAMERICAN:INFU) last issued its quarterly earnings data on Thursday, August 8th. The medical instruments supplier reported $0.03 EPS for the quarter, missing analysts’ consensus estimates of $0.04 by ($0.01). The company had revenue of $33.70 million for the quarter. InfuSystem had a net margin of 0.07% and a return on equity of 0.16%.

Institutional Trading of InfuSystem

Hedge funds have recently added to or reduced their stakes in the business. Rhumbline Advisers boosted its stake in InfuSystem by 13.8% during the 2nd quarter. Rhumbline Advisers now owns 17,658 shares of the medical instruments supplier’s stock valued at $121,000 after purchasing an additional 2,145 shares during the period. Marshall Wace LLP bought a new stake in InfuSystem during the 2nd quarter valued at approximately $131,000. Oppenheimer Asset Management Inc. boosted its stake in InfuSystem by 52.1% during the 2nd quarter. Oppenheimer Asset Management Inc. now owns 26,042 shares of the medical instruments supplier’s stock valued at $178,000 after purchasing an additional 8,917 shares during the period. Panagora Asset Management Inc. bought a new stake in InfuSystem during the 2nd quarter valued at approximately $208,000. Finally, ARS Investment Partners LLC boosted its stake in InfuSystem by 11.4% during the 2nd quarter. ARS Investment Partners LLC now owns 33,510 shares of the medical instruments supplier’s stock valued at $229,000 after purchasing an additional 3,422 shares during the period. Institutional investors own 71.13% of the company’s stock.

About InfuSystem

InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.